Skip to main content

3 Result(s)

within Article Remove this filter Chuanjian Tu Remove this filter

and

  1. No Access

    Article

    Clinicopathological differences and survival benefit in ER+/PR+/HER2+ vs ER+/PR−/HER2+ breast cancer subtypes

    Breast cancer subtypes based on estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression have significant implications for prognosis. HER2-positive tum...

    Wu Ding, Dengfeng Ye, Haifeng Chen, Yingli Lin, Zhian Li, Chuanjian Tu in Breast Cancer (2024)

  2. Article

    Open Access

    Dynamic changes in marital status and survival in women with breast cancer: a population-based study

    Marital status proved to be an independent prognostic factor for survival in patients with breast cancer. We therefore strove to explore the impact of dynamic changes in marital status on the prognosis of brea...

    Wu Ding, Guodong Ruan, Yingli Lin, Jianming Zhu, Chuanjian Tu… in Scientific Reports (2021)

    Download PDF (2472 KB) View Article

  3. No Access

    Article

    Efficacy and toxicity of extended aromatase inhibitors after adjuvant aromatase inhibitors-containing therapy for hormone-receptor-positive breast cancer: a literature-based meta-analysis of randomized trials

    Endocrine therapy with aromatase inhibitors (AIs) is the cornerstone of adjuvant systemic treatment for postmenopausal patients with hormone receptor-positive breast cancer. It has become clear that hormone re...

    **aoying Qian, Zhian Li, GuoDong Ruan, Chuanjian Tu… in Breast Cancer Research and Treatment (2020)